Product Images Ranolazine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Ranolazine NDC 42385-963 by Laurus Generics Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Ranolazine Extended Release Tablets 1000 mg - NDC 42385-964-60- 60 Tablets Label - ranolazine ext rel tabs 1000mg 60s label

Ranolazine Extended Release Tablets 1000 mg - NDC 42385-964-60- 60 Tablets Label - ranolazine ext rel tabs 1000mg 60s label

NDC 42385-964-60 is a Ranolazine extended-release tablet used for treating chronic angina. These tablets should be swallowed whole and not crushed, broken or chewed. The package insert should be consulted for dosage instructions. The medication should be stored at a temperature of 25°C with slight temperature excursions allowed. It is important not to use the product if the safety seal under the cap is broken or missing. These tablets are manufactured by VKT Pharma Private Limited in India and are distributed by Laurus Generics Inc. KEEP OUT OF REACH OF CHILDREN.*

Ranolazine Extended Release Tablets 500 mg - NDC 42385-963-60- 60 Tablets Label - ranolazine ext rel tabs 500mg 60s label

Ranolazine Extended Release Tablets 500 mg - NDC 42385-963-60- 60 Tablets Label - ranolazine ext rel tabs 500mg 60s label

NDC 42385-963-60 is a prescription medication containing Ranolazine, which is available in the form of extended-release tablets. Patients are advised not to crush, chew, or break the tablets and to swallow them whole. The package contains 60 tablets, with each tablet containing 500mg of Ranolazine. Dosage and administration should be done as per the package insert. It's recommended to store the tablets at a temperature of 25°C (77°F), but temperature excursions are allowed between 15° to 30°C (59° to 86°F). Patients should not use the medication if the printed safety seal under the cap is missing or broken. The drug should be kept out of reach of children. The manufacturer of the medication is VKT Pharma Private Limited located in Srikakulam, India-532 409, and it is manufactured for Laurus Generics Inc. located in Berkeley Heights, NJ 07922. The batch of the tablet was last revised in February 2022.*

Structure - ranolazine ext rel tabs structure

Structure - ranolazine ext rel tabs structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.